Lakeside Holdings Ltd. reported Q2 revenue of USD 7.01 million (+95.0%) for the quarter ended Dec. 31, 2025, with gross profit of USD 1.91 million versus a gross loss in the prior-year quarter. Net loss attributable to shareholders was USD 1.58 million for Q2, compared with USD 1.95 million a year earlier. For the six months ended Dec. 31, 2025, revenue was USD 13.11 million (+70.8%), gross profit was USD 3.02 million, and net loss attributable to shareholders was USD 2.94 million (vs. USD 3.28 million in the prior-year period). The company highlighted growth in its pharmaceutical distribution business, which began generating revenue in December 2024: Q2 revenue from pharmaceutical distribution was USD 2.44 million (about 11.2x year over year) and H1 revenue was USD 3.78 million (about 17.3x). In cross-border logistics, Q2 revenue from cross-border freight solutions was USD 4.57 million (+35.3%), with airfreight revenue of USD 3.62 million (+81.0%) and ocean freight revenue of USD 0.95 million (-31.2%). Lakeside also cited ongoing uncertainty from U.S.-China trade restrictions and noted that, as of Aug. 29, 2025, the U.S. permanently eliminated the USD 800 de minimis threshold for duty-free low-value shipments, increasing customs complexity and potentially reducing low-value parcel volumes handled by freight forwarders.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lakeside Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-018466), on February 19, 2026, and is solely responsible for the information contained therein.
Comments